8-K: Solitron Devices Reports Q2 FY26 Loss Amid Strong Bookings

Solitron Devices, Inc. announced fiscal 2026 second quarter results, reporting a net loss despite significant increases in net sales, bookings, and backlog.

Summary

• Net sales increased 11% to $3.99 million in fiscal 2026 second quarter compared to $3.58 million in the prior year's second quarter.
• Net bookings surged 147% to $4.32 million in fiscal 2026 second quarter from $1.75 million in the prior year.
• Backlog grew 146% to a record $18.64 million at the end of fiscal 2026 second quarter, up from $7.57 million in the prior year.
• The company reported a net loss of $0.23 million, or $0.11 per share, for fiscal 2026 second quarter, compared to a net income of $0.02 million, or $0.01 per share, in the fiscal 2025 second quarter.
• The decrease in profit was primarily due to a one-time $225,000 fully vested stock grant to the board and management and a $105,000 accrual for the COO's stock options.
• Revenue for fiscal 2026 second quarter was $3.99 million, an increase from $2.70 million in the first quarter, aligning with previous expectations for sales growth.
• Tariffs and other miscellaneous items negatively impacted gross margin during the quarter.

Sentiment

Score: 4

Explanation: The company demonstrated strong top-line growth with increased sales, bookings, and record backlog, indicating robust demand for its products. However, a substantial net loss for the quarter and year-to-date, primarily driven by one-time stock-based compensation and accruals, along with negative impacts on gross margin from tariffs, overshadows the operational positives. The forward-looking statements regarding future AMRAAM orders and silicon carbide development offer potential for improvement, but current profitability is a concern.

Positives

• Net sales increased 11% year-over-year to $3.99 million.
• Net bookings saw a substantial 147% increase to $4.32 million year-over-year.
• Backlog reached a record level of $18.64 million, representing a 146% increase year-over-year and a sequential increase from $18.26 million in Q1 FY26.
• Sales increased sequentially from $2.70 million in Q1 FY26 to $3.99 million in Q2 FY26, meeting management's expectations for growth.
• Anticipate a significant AMRAAM Lot 39 order in Q3 FY26, expected to be approximately 10% larger in quantity and higher in pricing.
• Increased interest in new product development, including silicon carbide, with prototypes developed for potential customers.

Negatives

• Reported a net loss of $0.23 million, or $0.11 per share, in Q2 FY26, a decline from a net income of $0.02 million, or $0.01 per share, in Q2 FY25.
• Gross profit margin was negatively impacted by tariffs and other miscellaneous items.
• Operating income decreased significantly to a loss of ($291) thousand in Q2 FY26 from an income of $50 thousand in Q2 FY25.
• Selling, general and administrative expenses increased to $1.126 million in Q2 FY26 from $0.688 million in Q2 FY25, partly due to one-time stock grants and accruals totaling $330,000.
• Net sales for the six months ended August 31, 2025, decreased to $6.686 million from $7.548 million in the prior year period.
• Net income for the six months ended August 31, 2025, was a loss of ($570) thousand, compared to an income of $606 thousand in the prior year period.

Risks

• Potential adverse developments or changes in government budgetary spending and policy, including with respect to the war in Ukraine.
• Possibility of reduced government spending on programs in which the company participates.
• Impact of inflation and elevated interest rates on operations and financial performance.
• Adverse trends in the economy and the possibility of a recession.
• Management's estimates and assumptions regarding bookings, sales, and other metrics may prove to be incorrect.
• Uncertainty regarding the timing and size of orders from clients.
• Risks related to delivery schedules, liquidity, and cash position.
• Ability to make appropriate adjustments to the cost structure.
• Ability to properly account for inventory in the future.
• Demand for products and potential loss of, or reduction of business from, substantial clients.
• Dependence on government contracts, which are subject to termination, price renegotiations, and regulatory compliance.
• Ability to continue to integrate Micro Engineering Inc. (MEI) in an efficient and effective manner.
• The possibility that the MEI acquisition or any other acquisition or strategic transaction does not yield the desired or anticipated results or benefits.

Future Outlook

Management expects sales to stabilize at a steadier level in the fiscal 2026 third and fourth quarters. The company anticipates receiving the AMRAAM Lot 39 order in the fiscal 2026 third quarter, with expected quantities approximately 10% above the prior year's order and higher pricing due to the expiration of a multi-year agreement. There is continued optimism regarding new product development, particularly in silicon carbide, with prototypes currently undergoing customer testing to create additional revenue sources.

Management Comments

• We expected sales to start to increase during fiscal second quarter, before reaching a steadier level in the fiscal 2026 third and fourth quarters.
• The Company's backlog continues to remain at record levels.
• Our bookings have historically been lumpy and are difficult to predict with certainty.
• Based on conversations, it is our expectation that AMRAAM Lot 39 order will be received in the fiscal 2026 third quarter.
• We continue to see increased interest in new product development, including silicon carbide.
• We have developed various prototypes for testing by potential customers and continue to be optimistic about creating additional revenue sources.

Industry Context

Solitron Devices operates within the specialized military and aerospace semiconductor components market, a sector heavily influenced by government defense spending and technological advancements. The company's focus on custom-made products for the U.S. government and standard military-grade items positions it directly within the defense supply chain. The mention of increased interest in silicon carbide development aligns with broader industry trends towards advanced materials for high-power and high-frequency applications, crucial for next-generation defense and space technologies. The 'lumpy' nature of bookings, particularly for large government contracts like AMRAAM, is characteristic of the defense procurement cycle, where large orders are infrequent but significant.

Stakeholder Impact

• Shareholders: Experienced a net loss of ($0.11) per share for the quarter, a significant decline from prior year's profit. Future share price could be influenced by the realization of anticipated AMRAAM orders and new product development success, but current profitability issues are a concern.
• Employees/Management: Received a one-time fully vested stock grant totaling $225,000, and the COO had a $105,000 stock option accrual, impacting company profitability.
• Customers (US Government/Defense Contractors): Continued strong demand for products, evidenced by increased bookings and backlog, with anticipation of a large AMRAAM order.
• Suppliers: Potential for increased demand due to higher bookings and backlog, but tariffs impacting gross margin could affect supplier negotiations or costs.

Next Steps

• Receive AMRAAM Lot 39 order in fiscal 2026 third quarter.
• Continue testing prototypes for new product development, including silicon carbide, with potential customers.
• Work towards sales reaching a steadier level in fiscal 2026 third and fourth quarters.
• File Annual Report on Form 10-K and Quarterly Report on Form 10-Q for respective periods with the SEC.

Key Dates

Recommendation

While Solitron Devices demonstrated impressive growth in net sales, bookings, and backlog, indicating strong market demand for its specialized military and aerospace components, the significant net loss for the quarter and year-to-date is a major concern. This loss was primarily driven by one-time compensation expenses and gross margin pressures from tariffs. The anticipated AMRAAM order and progress in silicon carbide development offer a positive future outlook, but the immediate profitability issues warrant caution. An investor should hold to observe if the company can translate its strong backlog into profitable revenue in the coming quarters and effectively manage its cost structure, especially after the one-time expenses.

Keywords

semiconductor components, military, aerospace, power transistors, MOSFETs, government contracts, Micro Engineering Inc., silicon carbide, defense industry, electronic components, Solitron Devices